Emerald Health Therapeutics Inc. Asset Turnover Ratio (EMHTF), as of fourth quarter 2019, current and historic results, rankings and more - CSIMarket
CSIMarket Company Name, Ticker, Customers, else..
 


• Sales per Employee
• Income per Employee
• Inventory Turnover
• Asset Turnover
• Receivables Turnover
Emerald Health Therapeutics Inc.  (EMHTF)
 

Emerald Health Therapeutics Asset Turnover Ratio

Quarterly Results, Trends, Rankings, Statistics

Emerald Health Therapeutics Inc. asset turnover ratio, the ability of Emerald Health Therapeutics Inc.'s assets to generate revenue in the fourth quarter 2019, increased sequentially to 0.13 in the fourth quarter (Dec 31 2019), yet the ratio remained below the average, as EMHTF's position remain challenging.

Within sector 181 more businesses have achieved higher asset turnover ratio. While asset turnover ranking remained unchanged in the fourth quarter 2019 compared to previous quarter at no. .

Asset Turnover Ratio Definition


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

EMHTF Asset Turnover Ratio (Dec 31 2019)
IV. Quarter		 0
III. Quarter		 0
II. Quarter		 0
I. Quarter		 (Dec 31 2018)
IV. Quarter
Y / Y Asset Change -37.64 % -24.38 % -24.38 % -24.38 % 87.66 %
Y / Y Revenue Change 328.38 % 2895.9 % 1620.44 % 565.31 % -
Asset Turnover Ratio (TTM) 0.13 0.1 0.04 0.02 0.01
EMHTF's Total Ranking # # # # #
Seq. Asset Change 17.45 % 0 % 0 % -46.91 % 42.43 %
Seq. Revenue Change -49.44 % 94.19 % 93.12 % 125.94 % 253.59 %



Asset Turnover Ratio Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 182
Healthcare Sector # 482
Overall Market #

Asset Turnover Ratio Statistics
High Average Low
0.14 0.14 0.14
(Dec 31 2019)  




EMHTF Company Profile • Back to EMHTF Efficiency Comparisons • Compare EMHTF Asset Turnover Ratio to its Competitors



Companies with similar Asset Turnover Ratio for the quarter ending Dec 31 2019, within Healthcare Sector Asset Turnover Ratio Revenues for 12 Months ending Dec 31 2019 Assets at quarter ending Dec 31 2019
Alexion Pharmaceuticals Inc   0.33 $ 4,991.100  Millions$ 15,231.725  Millions
Zimmer Biomet Holdings Inc   0.33 $ 7,982.200  Millions$ 24,362.150  Millions
Grifols Sa  0.33 $ 5,707.596  Millions$ 17,449.689  Millions
Mersana Therapeutics inc   0.33 $ 42.123  Millions$ 129.492  Millions
Chemocentryx Inc.  0.32 $ 72.256  Millions$ 223.143  Millions
Sanofi  0.32 $ 40,729.563  Millions$ 126,568.707  Millions
Axim Biotechnologies Inc   0.32 $ 0.799  Millions$ 2.492  Millions
Apyx Medical Corp  0.32 $ 28.235  Millions$ 88.107  Millions
Aspira Women s Health inc   0.32 $ 4.538  Millions$ 14.192  Millions
Cumberland Pharmaceuticals Inc   0.32 $ 34.388  Millions$ 107.620  Millions
Pfizer Inc  0.32 $ 51,750.000  Millions$ 162,388.750  Millions
Bio rad Laboratories Inc   0.31 $ 2,311.659  Millions$ 7,423.959  Millions
Assertio Holdings inc   0.31 $ 229.504  Millions$ 745.094  Millions
Oxford Immunotec Global Plc  0.31 $ 73.710  Millions$ 239.390  Millions
Mallinckrodt Plc  0.31 $ 3,162.500  Millions$ 10,368.050  Millions
Flexion Therapeutics Inc   0.30 $ 72.957  Millions$ 239.753  Millions
Viewray Inc   0.30 $ 87.782  Millions$ 290.221  Millions
Immunogen inc   0.30 $ 82.271  Millions$ 275.248  Millions
Cryoport inc   0.30 $ 33.942  Millions$ 113.558  Millions
Biocept Inc   0.30 $ 5.529  Millions$ 18.513  Millions
Endo International Plc  0.30 $ 2,914.364  Millions$ 9,775.502  Millions
Ngm Biopharmaceuticals Inc   0.30 $ 103.544  Millions$ 349.837  Millions
Kyntra Bio Inc   0.30 $ 256.577  Millions$ 869.706  Millions
Arcturus Therapeutics Holdings Inc   0.29 $ 20.789  Millions$ 71.179  Millions
Qiagen N v   0.29 $ 1,526.424  Millions$ 5,235.616  Millions
Avadel Pharmaceuticals Plc  0.29 $ 55.680  Millions$ 191.056  Millions
China Pharma Holdings Inc  0.29 $ 10.924  Millions$ 37.602  Millions
Vtv Therapeutics Inc   0.29 $ 2.764  Millions$ 9.549  Millions
Teva Pharmaceutical Industries Limited  0.29 $ 16,888.000  Millions$ 58,498.500  Millions
Adamas Pharmaceuticals Inc  0.29 $ 54.637  Millions$ 191.514  Millions



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.